Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26.7K | $20.1K | $2.7M | $39.8M | $130.0M | $157.1M | $145.1M | $140.8M |
| Cost of revenue | $7.7K | $7.9K | $1.8M | $25.9M | $69.1M | $99.0M | $77.8M | $71.1M |
| Gross profit | $19.0K | $12.2K | $868.1K | $13.9M | $60.9M | $58.1M | $67.3M | $69.7M |
| Gross margin | 71.3% | 60.7% | 32.5% | 34.8% | 46.8% | 37.0% | 46.4% | 49.5% |
| R&D | $0 | $0 | $6 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$228.1K | −$124.0K | −$14.8M | −$96.6M | −$222.3M | −$192.7M | −$89.3M | −$61.3M |
| EBITDA | −$221.6K | −$124.0K | −$13.2M | −$91.4M | −$198.8M | −$149.0M | −$54.8M | −$63.7M |
| Net income | −$228.1K | −$124.1K | −$15.4M | −$112.3M | −$277.0M | −$475.7M | −$145.4M | −$165.6M |
| Net margin | -856.0% | -618.7% | -577.1% | -282.2% | -213.2% | -302.8% | -100.3% | -117.6% |
| EPS (diluted) | -0.56 | -0.21 | -26.33 | -2.77 | -2.62 | -1.76 | -0.27 | -0.14 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds MMNFF.
No tracked institution reports a position in MMNFF as of their last filing.
No one on the platform has traded MMNFF yet.
| +1.99% |
| $0 |
| — |
| MRVTMiravant Medical Technologies Inc. | $0.00 | +29900.00% | $113571 | — |
| POTNPotNetwork Holdings, Inc. | $0.00 | +0.00% | $90997 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$TLRY I invested in 1.3million shares of Medmen over many years . The story that was being painted on TV and otherwise (especially around August 2021 ) was that it had tremendous value. Not sure why my shares say $0 on Fidelity account. $MMNFF $MSOS
View on StockTwits ↗$MMNFF Case Number: 25SMCV06818 - MMIRF, LLC victory would publicly expose Tilray and Serruya's predatory tactics https://www.reddit.com/r/mmnff/comments/1u8yzkz/case_number_25smcv06818_mmirf_llc_victory_would/
View on StockTwits ↗$GLASF Imagine MedMen joining up with Glasshouse. $MMNFF $TLRY
View on StockTwits ↗$TLRY $MMNFF Tilray’s positioning appears highly strategic. They systematically let the debt-ridden corporate entity of MedMen die, used their position to seize the premier physical retail real estate assets, and are now sitting on a turn-key U.S. infrastructure just as the gates of federal compliance are swinging wide open.
View on StockTwits ↗$TLRY The scale of the failure is crystallized in the creditor claims, which exceed 560 million Canadian dollars. In Los Angeles, a court-appointed administrator is currently overseeing the dissolution of the company's California assets. The focus is on the orderly liquidation of its subsidiary, MM CAN USA. While other players in the U.S. cannabis sector position themselves for potential federal reforms and a market re-rating, MedMen is absent from these future scenarios. The firm is no longer an active market participant but exists purely as an administrative case focused on disposing of residual assets. $MMNFF
View on StockTwits ↗$MMNFF READ new article at reddit ! Serruya, Simon (Tilray CEO), Ormond all only wanted to drain Medmen out of cannabis licenses, acted like enemies from within ! (July 30th where Tilray has asked for a Quash of the lawsuit, it should be REFUSED by the LA judge !). The betrayal case must be investigated, Medmen balance sheets. : r/mmnff https://www.reddit.com/r/mmnff/comments/1ty9rlb/serruya_simon_tilray_ceo_ormond_all_only_wanted/
View on StockTwits ↗$TLRY Understand that the board votes who is the boss. https://finance.yahoo.com/news/tilray-buys-convertible-debt-pot-233214995.html $MMNFF $MSOS $MJ
View on StockTwits ↗$MMNFF someone mentioned a billion dollar law suit they have against Tilray any truth to this ?
View on StockTwits ↗$TLRY $MMNFF Massive news for the US market once things get going for medical. Aug 2021 -Tilray said the $165.8 million deal would give it a footprint throughout the U.S., if cannabis is legalized at the federal level. In the deal, Tilray acquired 75% of Medmen’s outstanding secured convertible notes from Gotham Green Partners and 65% of its outstanding warrants. $CRON $ACB
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.